Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use
AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...
A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type 2 diabetes compared to...
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early IdentificationNEW ORLEANS, June 5,...
FRANKLIN, Tenn., June 5, 2026 /PRNewswire/ -- Xsolis, Inc. ("Xsolis"), a vendor that provides case and utilization management services to healthcare organizations, today announced...
Limited-time June offer helps fans feed the crowd during watch parties, game days and summer gatherings.DALLAS, June 5, 2026 /PRNewswire/ -- June is packed...
The First Time a Game in the Legendary Franchise Comes to ConsolesBELLEVUE, Wash., June 6, 2026 /PRNewswire/ -- Critically-acclaimed game development studio ArenaNet® tonight...
The First Time a Game in the Legendary Franchise Comes to ConsolesBELLEVUE, Wash., June 5, 2026 /PRNewswire/ -- Critically-acclaimed game development studio ArenaNet® tonight...